Cover Image

Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity

Dihydromyricetin (DMY), the main flavonoid component of Ampelopsis grossedentata, possesses pharmacological activities useful for treatment of diseases associated with inflammation and oxidative damage. Because osteoclasts are often involved in chronic low-grade systemic inflammation and oxidative d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Libo Zhao (Author), Cong Cai (Author), Jing Wang (Author), Liming Zhao (Author), Weijin Li (Author), Changyu Liu (Author), Hanfeng Guan (Author), Yuanli Zhu (Author), Jun Xiao (Author)
Format:	Book
Published:	Frontiers Media S.A., 2017-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Daily oral supplementation of Hochu-Ekki-To prevents osteoclastic activation and bone loss in ovariectomized mice
by: Shinsuke Ochiai, et al.
Published: (2021)

The Beneficial Effect of Praeruptorin C on Osteoporotic Bone in Ovariectomized Mice via Suppression of Osteoclast Formation and Bone Resorption
by: Xuqiang Liu, et al.
Published: (2017)

Effects of Taxifolin on Osteoclastogenesis in vitro and in vivo
by: Cong Cai, et al.
Published: (2018)

Daily intake of β-cryptoxanthin prevents bone loss by preferential disturbance of osteoclastic activation in ovariectomized mice
by: Kakeru Ozaki, et al.
Published: (2015)

Dihydromyricetin ameliorate postmenopausal osteoporosis in ovariectomized mice: Integrative microbiomic and metabolomic analysis
by: Lei Xu, et al.
Published: (2024)

Betulinic Acid Protects From Bone Loss in Ovariectomized Mice and Suppresses RANKL-Associated Osteoclastogenesis by Inhibiting the MAPK and NFATc1 Pathways
by: Jiyong Wei, et al.
Published: (2020)

3,3'-Diindolylmethane increases bone mass by suppressing osteoclastic bone resorption in mice
by: Tai-yong Yu, et al.
Published: (2015)

Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis
by: Chang-hong Li, et al.
Published: (2021)

Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity
by: Huang JM, et al.
Published: (2021)

Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis
by: Zeyuan Zhong, et al.
Published: (2020)

Corrigendum: Nitazoxanide, an antiprotozoal drug, reduces bone loss in ovariectomized mice by inhibition of RANKL-induced osteoclastogenesis
by: Chang-hong Li, et al.
Published: (2023)

Aqueous Extract of Salvia miltiorrhiza Bunge-Radix Puerariae Herb Pair Attenuates Osteoporosis in Ovariectomized Rats Through Suppressing Osteoclast Differentiation
by: Huan Qin, et al.
Published: (2021)

Isoliensinine Suppresses Osteoclast Formation Through NF-κB Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss
by: Huijiang Liu, et al.
Published: (2022)

Oleanolic acid exerts bone protective effects in ovariectomized mice by inhibiting osteoclastogenesis
by: Dongfeng Zhao, et al.
Published: (2018)

Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways
by: Xue Yang, et al.
Published: (2021)

The systemic bone protective effects of Gushukang granules in ovariectomized mice by inhibiting osteoclastogenesis and stimulating osteoblastogenesis
by: Qiang Wang, et al.
Published: (2018)

PTHG2 Reduces Bone Loss in Ovariectomized Mice by Directing Bone Marrow Mesenchymal Stem Cell Fate
by: Jiao Chen, et al.
Published: (2021)

The Molecular Mechanisms Study of Engeletin Suppresses RANKL-Induced Osteoclastogenesis and Inhibits Ovariectomized Murine Model Bone Loss
by: Feng M, et al.
Published: (2023)

Gut Clostridium sporogenes-derived indole propionic acid suppresses osteoclast formation by activating pregnane X receptor
by: Renpeng Peng, et al.
Published: (2024)

Regulation of bone and fat balance by Fructus Ligustri Lucidi in ovariectomized mice
by: Xiaoyan Qin, et al.
Published: (2023)

Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo
by: Sun P, et al.
Published: (2020)

Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss via Suppressing Osteoclastogenesis in Mice
by: Bao Huang, et al.
Published: (2019)

Pregnenolone Inhibits Osteoclast Differentiation and Protects Against Lipopolysaccharide-Induced Inflammatory Bone Destruction and Ovariectomy-Induced Bone Loss
by: Xiaochen Sun, et al.
Published: (2020)

The ameliorative role of specific probiotic combinations on bone loss in the ovariectomized rat model
by: Ahmad Gholami, et al.
Published: (2022)

Effect of dihydromyricetin on hepatic encephalopathy associated with acute hepatic failure in mice
by: Long Cheng, et al.
Published: (2021)

Mechanism of Dihydromyricetin on Inflammatory Diseases
by: Yang Sun, et al.
Published: (2022)

Estrogen Decreases Cytoskeletal Organization by Forming an ERα/SHP2/c-Src Complex in Osteoclasts to Protect against Ovariectomy-Induced Bone Loss in Mice
by: Hyun-Jung Park, et al.
Published: (2021)

Juglanin Inhibits Osteoclastogenesis in Ovariectomized Mice via the Suppression of NF-κB Signaling Pathways
by: Fangxue Zhang, et al.
Published: (2021)

Local administration of ReveromycinA ointment suppressed alveolar bone loss in mice
by: Ken Miyazawa, et al.
Published: (2021)

Effects of Erythromycin on Osteoclasts and Bone Resorption via DEL-1 Induction in Mice
by: Hikaru Tamura, et al.
Published: (2021)

Schisandrin B Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss
by: Jia Wang, et al.
Published: (2020)

Effects of Sparganii Rhizoma on Osteoclast Formation and Osteoblast Differentiation and on an OVX-Induced Bone Loss Model
by: Sungyub Lee, et al.
Published: (2022)

mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis
by: Manami Hiraiwa, et al.
Published: (2019)

Cirsilineol inhibits RANKL-induced osteoclast activity and ovariectomy-induced bone loss via NF-κb/ERK/p38 signaling pathways
by: Cong Wang, et al.
Published: (2024)

Asiatic Acid Attenuates Osteoporotic Bone Loss in Ovariectomized Mice Through Inhibiting NF-kappaB/MAPK/ Protein Kinase B Signaling Pathway
by: Mingming Dong, et al.
Published: (2022)

Er-Xian Decoction Stimulates Osteoblastic Differentiation of Bone Mesenchymal Stem Cells in Ovariectomized Mice and Its Gene Profile Analysis
by: Shufen Liu, et al.
Published: (2016)

Antidepressant-like Effect of Fuzi Total Alkaloid on Ovariectomized Mice
by: Lei Liu, et al.
Published: (2012)

Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo
by: Yu-Xi Li, et al.
Published: (2020)

Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease
by: Victor Gustavo Balera Brito, et al.
Published: (2020)

An Acid-Sensitive Bone Targeting Delivery System Carrying Acacetin Prevents Osteoporosis in Ovariectomized Mice
by: Xiaochen Sun, et al.
Published: (2022)